Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: How Biotech Gets Built is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
Few & Far Between: How Biotech Gets Built
52 minutes 5 seconds
8 months ago
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast!
Host Chris O'Brien welcomes Joshua Kresh, Emily Michiko Morris, and Mark Schultz from IPPI: The Intellectual Property Policy Institute. Tune in for a fascinating discussion on the dos and don'ts of IP protection.
Listen to the latest episode today!
Few & Far Between: How Biotech Gets Built
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
